Beckman Coulter Life Sciences Publishes Two Supplemental Protocols for RNA Isolation from Viral Samples
Methods Validated by Third-Party Laboratories in North America and Europe
(Indianapolis, Indiana - May 1, 2020) Beckman Coulter Life Sciences recently published two supplemental protocols1 for RNA isolation from viral samples and has available reagent inventory to ship to customers worldwide.
“The isolation of RNA from viral samples is a critical step for pathogen research,” said Mike Musgnug, vice president and general manager, Beckman Coulter Life Sciences’ Biotechnology Business Unit. “Our development team has worked closely with global research partners to provide customers viral extraction solutions during this time of increased need.”
Beckman Coulter Life Sciences partnered with Warsaw Genomics in Poland and iRepertoire in Huntsville, Alabama to develop methods for the protocols, and then the institutions independently validated the methods. All involved parties were pleased with the results.
“We performed more than 100 RNA extractions and more than 500 qPCR reactions during a three-day period to validate RNAdvance Viral XP,” said Miranda L. Byrne-Steele, Ph.D., Director of Operations and R&D, iRepertoire. “The results clearly demonstrate this new solution from Beckman Coulter Life Sciences a viable [extraction] alternative to help alleviate a critical supply chain shortage.”
The following supplemental protocols utilizing variations of RNAdvance Blood are available for review and download on beckman.com:
- Viral RNA extraction with RNAdvance Viral XP
- Viral Nucleic Acid extraction from Swabs using RNAdvance Viral
Please contact your Beckman Coulter Life Sciences genomic solutions sales representative if you have questions about the protocols or request more information on our website. We are currently experiencing significant demand increases for extraction kits, and thank you in advance for your patience, understanding and partnership.
Beckman Coulter genomic reagents and kits are not intended or validated for use in the diagnosis of disease or other conditions.
1The supplemental protocol is for demonstration only and is not validated by Beckman Coulter. Beckman Coulter makes no warranties of any kind whatsoever express or implied, with respect to this protocol, including but not limited to warranties of fitness for a particular purpose or merchantability or that the protocol is non-infringing. All warranties are expressly disclaimed. Your use of the method is solely at your own risk, without recourse to Beckman Coulter. Not intended or validated for use in the diagnosis of disease or other conditions.